IDKmonitor® Certolizumab drug level ELISA

Article number: KR9662

Test-Category

ELISA

Pack size

96 Tests

Possible sample matrix and volumes

Serum 10 µl
EDTA plasma 10 µl

Incubation periods

  1. 1 hour
  2. 1 hour
  3. 10-15 minutes

Indications

Regulatory Status

RUO (research use only)

IDKmonitor® Certolizumab drug level ELISA is an enzyme-linked immunosorbent assay (ELISA) for the quantitative determination of the free anti-TNFα therapy antibody Certolizumab (e.g. Cimzia®) in human serum. This assay is intended to be used by professional users in a laboratory environment. Not for use in diagnostic procedures. For research use only.

This might also be of interest